About Michael Chen
Michael Chen is a chief scientific officer at Seaport Therapeutics.
Michael Chen reports to the SEC as an officer of 1 public company.
Michael Chen first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Chen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Chen works with at each company, as listed on that company's latest Form D.
Seaport Therapeutics, Inc. · Form D, Oct 31, 2024
JH
James Healy
Director
LG
Lana Gladstein
General Counsel
DZ
Daphne Zohar
Executive officer and director
AL
Antony Loebel
Executive officer
DW
David Wheadon
Director
EG
Eric Green
Executive officer
RN
Robert Nelsen
Director
SP
Steven Paul
Director
BC
Bharatt Chowrira
Director
DT
Denice Torres
Director
EE
Eric Elenko
Director
JP
Jason Pitts
Director